Power Law company profile

Inscripta

Biotech & Life Sciences · Boulder, United States · Founded 2015 Colt

Developing the world’s first benchtop platform for scalable digital genome engineering

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

12 investors on Inscripta's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 12 investors entered at this stage

JS Capital Management

D1 Capital Partners

Mérieux Equity Partners

+ND Capital

Venrock

T. Rowe Price

Durable Capital Partners

Paladin Capital Group

Oak HC/FT

Foresite Capital

Morgan Stanley

Fidelity Investments

Global footprint

Where Inscripta has talent and traffic

AI talent share

8.3% of workforce is AI talent
(2 of 24 staff)

Core AI14.17%

Other AI14.17%

Non-AI workforce2291.67%

Workforce by country

🇺🇸 United States · Boulder HQ

Book a demo for the full country breakdown

Web traffic by country

1.7K monthly visits
across markets

🇺🇸 United States94.1%

🇮🇳 India5.9%

Top 2 markets shown

Market sentiment

What the market is saying about Inscripta

An AI-synthesized read of the highest-engagement posts about Inscripta on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inscripta on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles